In Metastatic breast cancer Kryxana 200mg Tablet helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. This medicine is used when other medicines have not shown significant improvement and the cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Kryxana 200mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
It is not known whether it is safe to consume alcohol with Kryxana 200mg Tablet. Please consult your doctor.
Kryxana 200mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Kryxana 200mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Kryxana 200mg Tablet may cause side effects which could affect your ability to drive. Some people may experience fatigue, dizziness, or vertigo during treatment with Kryxana 200mg Tablet. If these happen you should be cautious when driving or using machines.
Kryxana 200mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Kryxana 200mg Tablet may not be needed in these patients. Please consult your doctor.
Kryxana 200mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Kryxana 200mg Tablet may be needed. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More